
Yorkville Advisors
Description
Yorkville Advisors is a global investment manager headquartered in Mountainside, New Jersey, specializing in customized structured debt and equity investments. The firm primarily focuses on providing capital to small and mid-cap public companies across various sectors, including biotechnology, natural resources, and technology. Unlike traditional venture capital firms that typically invest in private startups, Yorkville Advisors engages in alternative financing structures, often serving as a capital provider for companies that may face challenges accessing conventional funding channels.
The firm's investment strategy frequently involves Private Investments in Public Equity (PIPEs), convertible notes, and equity lines of credit. These structures typically allow companies to raise capital by issuing securities that can be converted into common stock. A key characteristic of these arrangements is that conversion prices are often linked to the market performance of the underlying stock, which can lead to significant dilution for existing shareholders if the stock price declines. This approach positions Yorkville Advisors as a specialized financier for public entities seeking flexible capital solutions.
Yorkville Advisors' typical financing facilities, which represent their capital commitments, often range from approximately $10 million to $50 million. For example, public records indicate that the firm provided a $10 million convertible note facility to a company in the healthcare sector in 2010. In another instance, they extended a $50 million equity line to a different public entity in 2012. These figures illustrate the scale of their structured finance transactions, which are tailored to the specific capital needs of their public company clients. Their distinct focus on public market instruments differentiates them from early-stage venture capital investors.
Investor Profile
Yorkville Advisors has backed more than 53 startups, with 14 new investments in the last 12 months alone. The firm has led 37 rounds, about 70% of its total and boasts 31 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Post Ipo Equity, Post Ipo Debt, Seed rounds (top funding stages).
- Majority of deals are located in United States, Canada, Germany.
- Strong thematic focus on Biotechnology, Health Care, Medical.
- Led 13 rounds in the past year.
- Typical check size: $10M – $50M.
Stage Focus
- Post Ipo Equity (66%)
- Post Ipo Debt (26%)
- Seed (4%)
- Series Unknown (4%)
Country Focus
- United States (57%)
- Canada (11%)
- Germany (8%)
- Israel (6%)
- United Kingdom (4%)
- Switzerland (4%)
- Hong Kong (4%)
- Sweden (2%)
- France (2%)
- China (2%)
Industry Focus
- Biotechnology
- Health Care
- Medical
- Electric Vehicle
- Biopharma
- Manufacturing
- Genetics
- Therapeutics
- Pharmaceutical
- Software
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.